No Data
Cantor Fitzgerald Initiates Voyager Therapeutics(VYGR.US) With Buy Rating
Cantor Fitzgerald Initiates Voyager Therapeutics at Overweight
Solid Biosciences Stock Jumps 11% Post-market on FDA Update
Voyager Therapeutics, Inc. (VYGR): Is This Gene Therapy Stock a Good Buy Right Now?
Institutional Investors Own a Significant Stake of 48% in Voyager Therapeutics, Inc. (NASDAQ:VYGR)
Wall Street Analysts See a 152.53% Upside in Voyager Therapeutics (VYGR): Can the Stock Really Move This High?
LEEER利爾 OP : Good news, it’s time to surge